SIRT1 and nasopharyngeal carcinoma: The results showed that all four SIRT-inhibitors decreased the clonogenic survival of both NPC cell lines, with EX527, AK1 and AGK2 being more effective compared to Sirtinol, suggesting that the activity of SIRT1 and − 2 might have a role in modulating the long-term viability of NPC cells.